Series authors address intersectional gender power relations and other factors that lead to inequities in maternal health.
WATCH on YOUTUBE
Participating in this video are:
Associate Professor Meghan Bohren
Unit Head, Gender & Women’s Health
University of Melbourne School of Population and Global Health, Australia
Professor Shakila Thangaratinam
Dame Hilda Lloyd Professor of Maternal and Perinatal Health
StepMagSimplified Treatment for Eclampsia Prevention using Magnesium sulfate: A phase III, randomized, open label, active controlled, multicountry, multicentre, non-inferiority trial of simplified magnesium sulfate regimen for eclampsia prophylaxi.
IvonIron deficiency anaemia (IDA) is the commonest cause of AIP, accounting for 50-75% of AIP. We aim to compare the effectiveness of intravenous ferric carboxymaltose (intervention) versus oral ferrous sulphate (control) for treating anaemia and IDA in pregnancy and to measure acceptability, feasibility, fidelity (implementation outcomes) and the cost-effectiveness of intravenous iron among pregnant Nigerian women with moderate and severe anaemia at 20–32 weeks’ gestation.
E-MotiveThe E-MOTIVE trial is the Early detection of Postpartum Haemorrhage and treatment using the WHO MOTIVE 'first response' bundle: a cluster randomised trial with health economic analysis and mixed methods evaluation
Sudden Cardiac Arrest
To produce skilled human resource for health related to population health with focus of conducting research to achieve sustainable development through linking research findings to policy implementation.
To be a center of Excellence in Population Health, Research and Development in Africa.
The African Centre of Excellence for Population Health and Policy (ACEPHAP) is one of the World Bank supported African Centre of Excellence which is aimed at strengthening interdisciplinary approaches to promote population health outcome through training and research for evidence-informed policy development in West and Central Africa.